{ "cik": 1626971, "cik_padded": "0001626971", "entityName": "Corvus Pharmaceuticals, Inc.", "fiscal_years": [ { "accn": "0001104659-26-027047", "filed": "2026-03-12", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 174000.0, "cash": 4576000.0, "eps_diluted": -0.53, "free_cash_flow": -32971000.0, "net_income": -15283000.0, "operating_cash_flow": -32797000.0, "operating_income": -42971000.0, "stockholders_equity": 61205000.0, "total_assets": 71119000.0, "total_liabilities": 9914000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1619802303733355, "roa_avg2y": -0.21828803222258725, "roa_period_end": -0.21489334776923186, "roe_avg2y": -0.3259573651264223, "roe_period_end": -0.24970182174658934 } }, { "accn": "0001104659-26-027047", "filed": "2026-03-12", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 8740000.0, "eps_diluted": -1.02, "net_income": -62293000.0, "operating_cash_flow": -25424000.0, "operating_income": -27548000.0, "stockholders_equity": 32568000.0, "total_assets": 68907000.0, "total_liabilities": 36339000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1157885040530582, "roa_avg2y": -1.0884675869299318, "roa_period_end": -0.9040155572002846, "roe_avg2y": -1.7485263571548868, "roe_period_end": -1.9127057234094818 } }, { "accn": "0001558370-25-003621", "filed": "2026-03-12", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 34000.0, "cash": 12620000.0, "eps_diluted": -0.56, "free_cash_flow": -23969000.0, "net_income": -27029000.0, "operating_cash_flow": -23935000.0, "operating_income": -23407000.0, "stockholders_equity": 38684000.0, "total_assets": 45553000.0, "total_liabilities": 6869000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.17756695274532105, "roa_avg2y": -0.47505558338386367, "roa_period_end": -0.5933527978398788, "roe_avg2y": -0.570238082680197, "roe_period_end": -0.6987126460552165 } }, { "accn": "0001558370-25-003621", "filed": "2026-03-12", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 269000.0, "cash": 13159000.0, "eps_diluted": -0.89, "free_cash_flow": -27292000.0, "net_income": -41307000.0, "operating_cash_flow": -27023000.0, "operating_income": -32565000.0, "stockholders_equity": 56115000.0, "total_assets": 68240000.0, "total_liabilities": 12125000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2160741334758977, "roa_avg2y": -0.46492022848138664, "roa_period_end": -0.6053194607268464, "roe_avg2y": -0.5389849749146969, "roe_period_end": -0.7361133386794976 } }, { "accn": "0001558370-25-003621", "filed": "2025-03-25", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5000.0, "cash": 63458000.0, "eps_diluted": -1.03, "free_cash_flow": -36720000.0, "net_income": -43241000.0, "operating_cash_flow": -36715000.0, "operating_income": -38630000.0, "stockholders_equity": 97162000.0, "total_assets": 109455000.0, "total_liabilities": 12293000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12652065622362652, "roa_avg2y": -0.4435338284166906, "roa_period_end": -0.39505732949614, "roe_avg2y": -0.5107908570078554, "roe_period_end": -0.445040242069945 } }, { "accn": "0001558370-24-003567", "filed": "2024-03-19", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 76000.0, "cash": 16455000.0, "eps_diluted": -0.2, "free_cash_flow": -34854000.0, "net_income": -5995000.0, "operating_cash_flow": -34778000.0, "operating_income": -43760000.0, "stockholders_equity": 72148000.0, "total_assets": 85529000.0, "total_liabilities": 13381000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.18546598658313468, "roa_avg2y": -0.07087335599231565, "roa_period_end": -0.0700931847677396, "roe_avg2y": -0.08369456718251558, "roe_period_end": -0.08309308643344236 } }, { "accn": "0001558370-23-004792", "filed": "2023-03-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 25000.0, "cash": 5154000.0, "eps_diluted": -1.59, "free_cash_flow": -37346000.0, "net_income": -46672000.0, "operating_cash_flow": -37321000.0, "operating_income": -48854000.0, "stockholders_equity": 71111000.0, "total_assets": 83646000.0, "total_liabilities": 12535000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.17627371292767646, "roa_avg2y": -0.46237826806288945, "roa_period_end": -0.5579704947038711, "roe_avg2y": -0.5144422338203443, "roe_period_end": -0.6563260255094149 } }, { "accn": "0001558370-22-003281", "filed": "2022-03-10", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 355000.0, "cash": 39196000.0, "free_cash_flow": -41343000.0, "net_income": -46939000.0, "operating_cash_flow": -40988000.0, "operating_income": -49222000.0, "stockholders_equity": 110336000.0, "total_assets": 118232000.0, "total_liabilities": 7896000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.07156322505800464, "roa_avg2y": -0.4407273000417827, "roa_period_end": -0.39700757832059, "roe_avg2y": -0.48100383766030813, "roe_period_end": -0.4254187209976798 } }, { "accn": "0001558370-21-003462", "filed": "2021-03-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 266000.0, "cash": 45106000.0, "free_cash_flow": -46478000.0, "net_income": -55663000.0, "operating_cash_flow": -46212000.0, "operating_income": -56524000.0, "stockholders_equity": 84835000.0, "total_assets": 94775000.0, "total_liabilities": 9940000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11716862144162198, "roa_avg2y": -0.4738788975204853, "roa_period_end": -0.5873173305196518, "roe_avg2y": -0.5115238287783271, "roe_period_end": -0.6561324924854128 } }, { "accn": "0001558370-20-002232", "filed": "2020-03-09", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2199000.0, "cash": 5050000.0, "free_cash_flow": -30056000.0, "net_income": -36375000.0, "operating_cash_flow": -27857000.0, "operating_income": -36976000.0, "stockholders_equity": 132801000.0, "total_assets": 140150000.0, "total_liabilities": 7349000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05533843871657593, "roa_period_end": -0.25954334641455584, "roe_period_end": -0.27390606998441275 } }, { "accn": "0001047469-18-001209", "filed": "2018-03-01", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "capex": "USD" }, "fundamentals": { "capex": 1747000.0 }, "period_end": "2015-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001104659-26-027047", "filed": "2026-03-12", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001626971.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001626971.json" }, "ticker": "CRVS" }